Cardioprotective effects of diltiazem reevaluated by a novel myocardial ischemic model in Chinese miniature swine

Acta Pharmacologica Sinica

Volumn 28, Issue 1, 2007, Pages 52-57

  Liu, Jian Xun ^a   Yu, Zhen ^a   Li, Xin Zhi ^a   Fu, Jian Hua ^a   Shang, Xiao Hong ^a   Yan, Ai Guo ^a   Shi, Yue ^a   Ma, Yan Lei ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Animal models; Chinese miniature swine; Diltiazem; Myocardial ischemia

Indexed keywords

DILTIAZEM; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANGIOCARDIOGRAPHY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BIOCHEMISTRY; BODY SURFACE; CELL DEGENERATION; CELL INFILTRATION; CONTROLLED STUDY; DIET; ELECTROCARDIOGRAM; FEMALE; GRANULATION TISSUE; HEART INDEX; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART OUTPUT; HEART PROTECTION; HEART WORK; HEMODYNAMICS; HISTOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MINIPIG; NONHUMAN; PATHOPHYSIOLOGY; QUANTITATIVE HISTOCHEMISTRY; SELF INJECTION; SYSTEMIC VASCULAR RESISTANCE;

EID: 33845992856     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00464.x     Document Type: Article

References (17)

1. Pantely GA, Bristow JD. Ischemic cardiomyopathy. Prog Cardiovasc Dis 1984; 27: 95-114.
2. Klassen GA, Yeung PK, Barclay KD, Pollak PT, Hung OR, Buckley SJ. Effect of diltiazem on intraarterial blood pressure and heart rate during stress testing in patients with angina: a gender comparison study. J Clin Pharmacol 1997; 37: 297-303.
3. Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete infarction trial of European research collaborators evaluating prognosis post-thrombolysis (INTERCEPT). Lancet 2000; 355: 1751-6.
4. Parameshwar J, Poole-Wilson PA. The role of calcium antagonists in the treatment of chronic heart failure. Eur Heart J 1993; 14 (Suppl A): 38-44.
5. Reicher-Reiss H, Barasch E. Calcium antagonists in patients with heart failure. Drugs 1990; 42: 343-64.
6. Takahashi M, Tanonaka K, Yoshida H, Koshimizu M, Oikawa R, Daicho T, et al. Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligation. Eur J Pharmacol 2005; 522: 4-93.
7. Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 2000; 292: 795-802.
8. Huang Y, Hunyor SN, Jiang L, Kawaguchi O, Shirota K, Ikeda Y, et al. Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses. Am J Physiol Heart Circ Physiol 2004; 286: H2141-50.
9. Dogne JM, Rolin S, Petein M, Tchana-Sato V, Ghuysen A, Lambermont B, et al. Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig. Thromb Res 2005; 116: 431-42.
10. Kang RT, Li XS, Cao RQ, Wu WH, Dong ZM. Effects of propofol on lung injury following ischemia-reperfusion of hind limbs in rats. Chin J Anesthesiol 2005; 25: 346-50.
11. Liu JX, Shang XH, Fu JH, Li XZ, Wang G. Effects of recombinant staphylokinase on coronary thrombosis in Chinese experimental miniature swine. Acta Pharmacol Sin 2002; 23: 509-15.
12. Hughes GC, Post MJ, Simons M, Annex BH. Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. J Appl Physiol 2003; 94: 1689-701.
13. Lacoursiere L, Millward S, Veinot JP, Labinaz M. Percutaneous removal of pulmonary artery emboli with hydrolyser catheter in pigs. Can Assoc Radiol J 2001; 52: 118-25.
14. Busch E, Kruger K, Hossmann KA. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res 1997; 778: 16-24.
15. van der Vring JA, Daniels MC, Holwerda NJ, Withagen PJ, Schelling A, Cleophas TJ, et al. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands working group on cardiovascular research (WCN). Angiology 1999; 50: 447-54.
16. Nicolau JC, Ramires JA, Maggioni AP, Garzon SA, Pinto MA, Silva DG, et al. Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase. The Calcium Antagonist in Reperfusion Study (CARES) Group. Am J Cardiol 1996; 78: 1052-79.
17. Tadokoro H, Miyazaki A, Satomura K, Ryden L, Kaul S, Kar S, et al. Infarct size reduction with coronary venous retroinfusion of diltiazem in the acute occlusion/reperfusion porcine heart model. J Cardiovasc Pharmacol 1996; 28: 134-41.